Vitamin D supplementation in a healthy, middle-aged population: Actual practices based on data from a French comprehensive regional health-care database

European Journal of Clinical Nutrition

Volumn 67, Issue 11, 2013, Pages 1133-1137

  Caillet, P ^a,b   Souberbielle, J C ^c   Jaglal, S B ^d   Reymondier, A ^a   Van Ganse, E ^e   Chapurlat, R ^b   Schott, A M ^a,b,f  

^a HOSPICES CIVILS DE LYON   (France)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITÉ DE LYON   (France)

Author keywords

Adult; Middle aged; Pharmacoepidemiology; Vitamin D; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL;

ADULT; AGE; AMPOULE; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; DATA BASE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; FRANCE; HUMAN; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; REIMBURSEMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; BONE DENSITY CONSERVATION AGENTS; CHOLECALCIFEROL; COMORBIDITY; DIETARY SUPPLEMENTS; FEMALE; FRANCE; GUIDELINES AS TOPIC; HEALTH; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS; REFERENCE VALUES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 84887403859     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2013.182     Document Type: Article

References (29)

1. Turner AG, Anderson PH, Morris HA. Vitamin D and bone health. Scand J Clin Lab Invest 2012; 243(Suppl): 65-72.
2. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol 2009; 19: 468-483.
3. Gorham ED, Garland CF, Burgi AA, Mohr SB, Zeng K, Hofflich H et al. Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nested case-control study. Diabetologia 2012; 55: 3224-3227.
4. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-1503. (Pubitemid 33055701)
5. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838. (Pubitemid 44969183)
6. Vidailhet M, Mallet E, Bocquet A, Bresson J-L, Briend A, Chouraqui J-P et al. Vitamin D: still a topical matter in children and adolescents. A position paper by the Committee on Nutrition of the French Society of Paediatrics. Arch Pediatr 2012; 19: 316-328.
7. Benhamou CL, Souberbielle J-C, Cortet B, Fardellone P, Gauvain J-B, Thomas T. La vitamine D chez l'adulte: recommandations du GRIO. Presse Med 2011; 40: 673-682.
8. Haute Autoritéde Santé [Internet]. Guide du parcours de soin-Maladie rénale chronique de l'adulte [cited 2013 Jul 26]; 2012 Feb. 56 p. Available from http://www.has-sante.fr/portail/upload/docs/application/ pdf/2012-04/guide-parcours-de-soins-mrc-web.pdf.
9. Dawson-Hughes B, Mithal A, Bonjour J-P, Boonen S, Burckhardt P, GE-H Fuleihan et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010; 21: 1151-1154.
10. Forrest KYZ, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 2011; 31: 48-54.
11. Vernay M. Statut en vitamine D de la population adulte en France: l'Étude nationale nutrition santé (ENNS, 2006-2007). BEH 2012; 16-17: 189.
12. Le Goaziou MF, Contardo G, Dupraz C, Martin A, Laville M, Schott-Pethelaz AM. Risk factors for vitamin D deficiency in women aged 20-50 years consulting in general practice: a cross-sectional study. Eur J Gen Pract 2011; 17: 146-152.
13. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA et al. IOM Committee Members Respond to Endocrine Society Vitamin D Guideline. J Clin Endocrinol Metab 2012; 97: 1146-1152.
14. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Guidelines for preventing and treating Vitamin D deficiency and insufficiency revisited. JCEM 2012; 97: 1153-1158.
15. Latry P, Molimard M, Bégaud B, Martin-Latry K. How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database. Eur J Clin Pharmacol 2010; 66: 743-748.
16. Assurance Maladie [Internet]. Fréquence des ALD au 31/12/2009 2012 Dec 14 [cited 2013 Jul 26]. Available at http://www.ameli.fr/l-assurance- maladie/statistiques-et-publications/donnees-statistiques/affection-de- longueduree-ald/prevalence/frequence-des-ald-au-31-12-2009.php.
17. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854-864. (Pubitemid 33000813)
18. Keipert JA. Stosstherapy: a fresh look at some principles of therapy-especially chemotherapy. Aust Paediatr J 1986; 22: 127-130. (Pubitemid 16017114)
19. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011; 6: CD007470.
20. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D et al. Vitamin D2 is as effective as Vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93: 677-681. (Pubitemid 351398538)
21. Pekkarinen T, Välimäki V, Aarum S, Turpeinen U, Hämäläinen E, Löyttyniemi E et al. The same annual dose of 292000 IU of vitamin D3 (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D3 concentrations and renal function. Clin Endocrinol (Oxf) 2010; 72: 455-461.
22. Jones KS, Schoenmakers I, Bluck LJC, Ding S, Prentice A. Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults. Br J Nutr 2012; 107: 1128-1137.
23. Webb AR. Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 2006; 92: 17-25. (Pubitemid 43831964)
24. Rouillon V, Dubourg G, Gauvain J-B, Baron D, Glemarec J, Cormier G et al. Vitamin D insufficiency: Evaluation of an oral standardized supplementation using 100,000 IU vials of cholecalciferol, depending on initial serum level of 25OH vitamin D. Joint Bone Spine 2012; 79: 399-402.
25. Bilinski K, Boyages S. The rise and rise of vitamin D testing. BMJ 2012; 345: e4743-e4743.
26. Breysse C. La supplémentation en vitamine D chez les personnes de plus de 65 ans: étude des pratiques de 100 médecins généralistes des Pays de la Loire [dissertation]. Université de Nantes 2010, p 69.
27. Noize P, Bazin F, Dufouil C, Lechevallier-Michel N, Ancelin M-L, Dartigues J-F et al. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf 2009; 18: 310-319.
28. Fender P, Weill A. [Epidemiology, public health and medical rates databases]. Rev Epidemiol Sante Publique] 2004; 52: 113-117. (Pubitemid 38678540)
29. Bogh MKB. Vitamin D production after UVB: aspects of UV-related and personal factors. Scand J Clin Lab Invest Suppl 2012; 243: 24-31.